FFA
OCUL icon

Farther Finance Advisors’s Ocular Therapeutix OCUL Stock Holding History

Farther Finance Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.4K Buy
2,012
+483
+32% +$4.73K ﹤0.01% 4348
2026
Q2 		$15K Buy
1,529
+277
+22% +$2.51K ﹤0.01% 4162
2026
Q1 		$10.4K Buy
1,252
+661
+112% +$6.3K ﹤0.01% 4082
2025
Q4 		$7.17K Sell
591
-355
-38% -$4.31K ﹤0.01% 4118
2025
Q3 		$11.1K Buy
946
+665
+237% +$7.95K ﹤0.01% 3401
2025
Q2 		$2.61K Sell
281
-689
-71% -$5.39K ﹤0.01% 3607
2025
Q1 		$6.34K Buy
970
+960
+9,600% +$7.38K ﹤0.01% 2946
2024
Q4 		$85 Hold
10
– – ﹤0.01% 3806
2024
Q3 		$87 Hold
10
– – ﹤0.01% 3803
2024
Q2 		$67 Hold
10
– – ﹤0.01% 3655
2024
Q1 		$87 Buy
+10
New +$71 ﹤0.01% 3399

Other funds holding OCUL

FMN
Financial Management Network Mission Viejo, California $695M AUM 13.16% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's OCUL Position: Q3 2026 in Review

Farther Finance Advisors increased its Ocular Therapeutix (OCUL) stake by 32% in Q3 2026, buying an estimated $4.73K and bringing the position to 2,012 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4348.

Farther Finance Advisors first reported a position in OCUL in Q1 2024 and has held it in 11 quarters since. 5 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Farther Finance Advisors held 2,012 shares of Ocular Therapeutix worth $15.4K as of Q3 2026.
  • Farther Finance Advisors bought 483 Ocular Therapeutix shares in Q3 2026, an estimated $4.73K.
  • Ocular Therapeutix made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4348 holding.
  • Farther Finance Advisors first reported a position in Ocular Therapeutix in Q1 2024 and has held it in 11 quarters since.
  • 5 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.